e-learning
resources
Vienna 2012
Tuesday, 04.09.2012
Pulmonary circulation: clinical treatment
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
The anti-proliferative effects of apelin on pulmonary adventitial fibroblasts
L. Brash, C. Church, R. Wadsworth, A. Peacock, D. Welsh (Glasgow, United Kingdom)
Source:
Annual Congress 2012 - Pulmonary circulation: clinical treatment
Session:
Pulmonary circulation: clinical treatment
Session type:
Oral Presentation
Number:
3272
Disease area:
Pulmonary vascular diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
L. Brash, C. Church, R. Wadsworth, A. Peacock, D. Welsh (Glasgow, United Kingdom). The anti-proliferative effects of apelin on pulmonary adventitial fibroblasts. Eur Respir J 2012; 40: Suppl. 56, 3272
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Muscle energy techniques for COPD patients: Effects on pulmonary function and activities of daily living
Related content which might interest you:
Anti-fibrotic effect of Atorvastatin on the lung fibroblasts and myofibroblasts
Source: International Congress 2018 – Pulmonary fibrosis: from models to patients
Year: 2018
Dexamethasone induces anti-remodelling effects in rat pulmonary arterial smooth muscle cells
Source: Annual Congress 2012 - Pulmonary circulation: basic mechanisms, animal models and cell biology
Year: 2012
Phosphodiesterase-type 3 inhibitor potentiates cAMP generation and antiproliferative effects of treprostinil in pulmonary arterial smooth muscle cells from patients with pulmonary hypertension
Source: Annual Congress 2010 - Pathobiology of pulmonary hypertension
Year: 2010
Fibroblasts positive for meflin have anti-fibrotic properties in pulmonary fibrosis
Source: Eur Respir J, 58 (6) 2003397; 10.1183/13993003.03397-2020
Year: 2021
The pro-proliferative phenotype of pulmonary microvascular endothelium
Source: Research Seminar 2005 - Pulmonary Circulation: Molecular Determinants of Pulmonary Vascular Remodelling
Year: 2005
In vitro effects of vasodilatory drugs on BMPR2-silenced pulmonary microvascular endothelial cell function
Source: Virtual Congress 2021 – Pathogenesis and pathophysiology of pulmonary hypertension
Year: 2021
Antifibrosic effects of sulforaphane in human lung fibroblasts from idiopathic pulmonary fibrosis
Source: Annual Congress 2011 - New insights in the treatment of idiopathic pulmonary fibrosis
Year: 2011
The effect of ASK1 inhibition on hypoxia-induced pulmonary artery fibroblast activation and associated paracrine effects on vascular smooth muscle cells
Source: International Congress 2016 – The nature of pulmonary hypertension
Year: 2016
Anti-fibrotic effects of pirfenidone on pulmonary arterial vascular smooth muscle cells
Source: International Congress 2016 – The nature of pulmonary hypertension
Year: 2016
The influence of dexamethasone on the proliferation and apoptosis of pulmonary inflammatory cells in bleomycin-induced pulmonary fibrosis in rats
Source: Eur Respir J 2002; 20: Suppl. 38, 487s
Year: 2002
Anti-inflammatory effect of bosentan on endothelin-1- and TNF-α-induced GMCSF expression in human airways smooth muscle cells – role of MAPkinases ERK-1,-2
Source: Annual Congress 2007 - Inflammatory cell biology
Year: 2007
Anti-inflammatory and anti-fibrotic effects of sirolimus in bleomycin-induced pulmonary fibrosis in rats
Source: Annual Congress 2010 - Experimental approaches in pulmonary fibrosis
Year: 2010
Role of EPAC in transmission of ß-adrenoceptor- and EP
2
-receptor-induced antiproliferative effects in human pulmonary fibroblasts
Source: Annual Congress 2007 - Recent advances in airway smooth muscle biology
Year: 2007
Antiproliferative effects of drugs affecting different signalling pathways on rat and human pulmonary artery smooth muscle cells
Source: International Congress 2015 – Pulmonary hypertension: rare and hereditary causes of PAH
Year: 2015
Effect of endothelin-1 and bosentan on gene expressions in the cultured pulmonary artery smooth muscle cells
Source: Annual Congress 2010 - Pulmonary vascular diseases
Year: 2010
Esterification of iloprost enhances its protective effects on pulmonary endothelium
Source: Respiratory Failure and Mechanical Ventilation Conference 2020
Year: 2020
NOX4/NADPH oxidase expression is increased in pulmonary fibroblasts from patients with idiopathic pulmonary fibrosis and mediates TGFβ1-induced fibroblast differentiation into myofibroblasts
Source: Annual Congress 2009 - From emphysema to fibrosis: mechanisms of cellular remodelling in the diseased lung
Year: 2009
Inhibition of HGF secretion by pulmonary fibroblasts from IPF: involvement of PGE2
Source: Eur Respir J 2003; 22: Suppl. 45, 8s
Year: 2003
VEGF reduces pulmonary hypertension and vascular remodeling in pulmonary fibrosis through reduced endothelial apoptosis
Source: Annual Congress 2009 - Pulmonary circulation I
Year: 2009
Different effects of mesenchymal stem cells on elastase-induced pulmonary emphysema and macrophages activity in rats
Source: Annual Congress 2011 - Recent developments in COPD
Year: 2011
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept